9
CVE-2015-3965
- EPSS 0.32%
- Veröffentlicht 23.03.2019 20:29:00
- Zuletzt bearbeitet 21.11.2024 02:30:09
- Quelle ics-cert@hq.dhs.gov
- CVE-Watchlists
- Unerledigt
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Pfizer ≫ Symbiq Infusion System Firmware Version <= 3.13
| Typ | Quelle | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.32% | 0.549 |
| Quelle | Base Score | Exploit Score | Impact Score | Vector String |
|---|---|---|---|---|
| nvd@nist.gov | 8.8 | 2.8 | 5.9 |
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
|
| nvd@nist.gov | 9 | 8 | 10 |
AV:N/AC:L/Au:S/C:C/I:C/A:C
|